01865 261400

BOOK A TOUR

News from our innovation centres

Get up-to-date with our latest news and discover how other founders have flourished by reading our case studies.

See our sister site the Wood Centre for Innovation for more latest news.

Filter by articles in
February 13th 2018

Absolute Antibody and Kerafast Merge to offer cutting-edge research tools

Absolute Antibody and Kerafast Merge to Increase Access to Unique Reagents and Recombinant Antibody Technology […]

January 29th 2018

Head-to-head with Oliver Gummery at Createc

Although a long way from its main office in Cumbria, Createc is one of the latest businesses to have moved in to OCFI. We met Oliver Gummery, one of the company’s product designers, to find out more about what they do.

November 28th 2017

Mirada Medical and Optellum announce collaboration

Mirada Medical and Optellum announce collaboration to accelerate Deep Learning based lung cancer diagnosis products and to present scientific results at the RSNA 2017 […]

November 21st 2017

Vitaccess

Why did an OCFI business capture the attention of Piers Morgan? […]

October 16th 2017

Head-to-head with Steve Whitla at Visual Meaning

Steve Whitla is passionate about maps. He is the founder and CEO of Visual Meaning, a company that helps large organisations make sense of how they work using conceptual maps. […]

July 18th 2017

Business competition launched to celebrate 30th anniversary

Oxford Centre for Innovation is helping to find the next Scale-up Star of the Future. A nationwide competition has been launched […]

June 27th 2017

Absolute Antibody New Director Appointment

Absolute Antibody Ltd is pleased to announce the appointment of Stevan Hoyle as a Non-Executive Director, effective immediately. […]

June 13th 2017

Oxford Innovation reaches a special milestone

This year marks an important year for Oxford Innovation as we celebrate 30 years of supporting ambitious entrepreneurs. […]

June 7th 2017

Absolute Antibody growth & investment accelerates

How these providers of engineered antibodies have seen significant progress with 195% growth over the previous year. […]